Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens
<title>Extract</title> With 10.7 million cases and 1.2 million deaths estimated for 2024, tuberculosis (TB) is a clinical and public health priority [1]. With the emergence of new drugs [2], the importance of improving existing treatment regimens has gained wide interest within the scientific community worldwide [3, 4].
Authors
- Alberto Piubello (ORCID: https://orcid.org/0000-0002-6937-3126)
- Erlina Burhan (ORCID: https://orcid.org/0000-0002-8115-8293)
- Yousra Kherabi (ORCID: https://orcid.org/0000-0002-6201-426X)
- Anh Tuan Dinh‐Xuan (ORCID: https://orcid.org/0000-0001-8651-5176)
- Onno W. Akkerman (ORCID: https://orcid.org/0000-0001-5638-9260)
- Adrián Rendón (ORCID: https://orcid.org/0000-0001-8973-4024)
- Simon Tiberi (ORCID: https://orcid.org/0000-0002-0738-4276)
- Ananthu James (ORCID: https://orcid.org/0000-0002-2562-347X)
- Lia D’Ambrosio (ORCID: https://orcid.org/0000-0002-7000-5777)
- Rosella Centis (ORCID: https://orcid.org/0000-0002-8551-3598)
- Molebogeng Xheedha Rangaka (ORCID: https://orcid.org/0000-0001-9594-188X)
- Ong C (ORCID: https://orcid.org/0000-0003-1103-0451)
- Simone Villa (ORCID: https://orcid.org/0000-0002-0753-8853)
- Christian Lienhardt (ORCID: https://orcid.org/0000-0003-0233-893X)
- Gina Gualano (ORCID: https://orcid.org/0000-0001-6149-0005)
- Emanuele Pontali (ORCID: https://orcid.org/0000-0002-1085-0442)
- Giovanni Battista Migliori (ORCID: https://orcid.org/0000-0002-2597-574X)
- Marina Tadolini (ORCID: https://orcid.org/0000-0002-1005-7532)
- Syed Karam Shah
- Denise Rossato Silva (ORCID: https://orcid.org/0000-0003-0230-2734)
- José-María García-García (ORCID: https://orcid.org/0000-0002-2809-6230)
- Rifat Mahfuza
- Mario C. Raviglione
- Ramesh Panchagnula
- Marcela Muñoz-Torrico
- Daria Podlekareva
- for the Global Tuberculosis Network and FAST-TB End-User Survey Group
- Muhammad Abdul Hamid Selim
- Tsion Asfaw Refera
- Najiha Rasheed
- Yang Li
- Fatma Alyaquobi
- Barbara Seaworth
- Alessandra Bellavia
- Cary Amiel Villanueva
- Irina Felker
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Statens Serum Institut (DK)
- National Tuberculosis Institute (IN)
- Universidade Federal do Rio Grande do Sul (BR)
- University Medical Center Groningen (NL)
- State University of Bangladesh (BD)
- Novosibirsk State Medical University (RU)
- Foundation University Islamabad (PK)
- Inserm (FR)
- National University of Singapore (SG)
- The University of Texas at San Antonio Health Science Center (US)
- Queen Mary University of London (GB)
- Universidad Autónoma de Nuevo León (MX)
- University of Groningen (NL)
- University of Milan (IT)
- Université Paris Cité (FR)
- Fudan University (CN)
- Bispebjerg Hospital (DK)
- Erasmus MC (NL)
- Research Foundation - Flanders (BE)
- Philippine General Hospital (PH)
- University of Indonesia (ID)
- Ente Ospedaliero Ospedali Galliera (IT)
- Istituti Clinici Scientifici Maugeri (IT)
- Hôpital Cochin (FR)
- Novosibirsk Tuberculosis Research Institute (RU)
- Assistance Publique – Hôpitaux de Paris (FR)
- Center for Prevention and Treatment of Infections (US)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- St. Mary's Hospital (US)
- Azienda USL di Bologna (IT)
- Sociedad Española de Neumología y Cirugía Torácica (ES)
- Hospital Universitario Dr José Eleuterio Gonzalez (MX)
- St. Mary’s Hospital (ZA)
- Centre for Multidisciplinary Research in Health Science (IT)
- Institute for Sustainable Development (ET)
- National Institute of Research in Tuberculosis (IN)
- Institut Cochin (FR)
- The London College (GB)
- Hôpital Bichat-Claude-Bernard (FR)
- Child Health Research Foundation (BD)
- Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT)
- Damien Foundation (BD)
- Texas Center for Infectious Disease (US)
- Center for Non-Communicable Diseases (PK)
- Biomedical Research Foundation (BD)
- Huashan Hospital (CN)
- Institut de Recherche pour le Développement (FR)
- Centre international de recherche sur le cancer (FR)
- Infection, Anti-microbiens, Modélisation, Evolution (FR)
- University College London (GB)
- Università della Svizzera italiana (CH)
- University of the Philippines Manila (PH)
- International Union Against Tuberculosis and Lung Disease (US)
- The University of Texas Health Science Center at Tyler (US)
- Erasmus University Rotterdam (NL)
- University of Bologna (IT)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2026-07-30
- DOI
- https://doi.org/10.1183/13993003.00989-2026
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases